CAS: 15852-73-0; (3-Bromophenyl)Methanol

相似化合物

1515-89-5 103978-12-7 24398-88-7

上下游产品

CAS号3132-99-8 间溴苯甲醛 | CAS号585-76-2 3-溴苯甲酸 | CAS号24398-88-7 3-溴苯甲酸乙酯 | CAS号823-78-9 间溴溴苄 | CAS号22726-00-7 3-溴苯甲酰胺 | CAS号7664-93-9 硫酸 | CAS号67-56-1 甲醇 | CAS号56-23-5 四氯化碳 | CAS号107558-73-6 2-(3-溴苄基)丙二酸二乙酯 | CAS号10602-07-0 (3-乙炔基苯基)甲醇 | CAS号42287-90-1 3-(3-溴苯基)丙酸 | CAS号3132-99-8 间溴苯甲醛 | CAS号585-76-2 3-溴苯甲酸 | CAS号34598-49-7 5-溴-1-茚酮 | CAS号874-97-5 3-羟甲基苯甲腈 | CAS号28286-79-5 3-羟甲基苯甲酸 | CAS号87199-15-3 3-(羟甲基)苯硼酸 | CAS号823-78-9 间溴溴苄

间溴苯甲酸置于苯硅烷,Cobalt(2+);Oxolane;9-Oxophenalen-1-Olate,氢化钾体系中,用 四氢呋喃 用作溶剂,化学反应 20.0H,以81%的收率获得3-溴苯甲醇
参考文献:在苯酚骨架中存储氧化还原当量以实现催化多电子还原†
标题:在苯酚骨架中存储氧化还原当量以实现催化多电子还原†
摘要:多电子还原过程的电子存储和转移被认为是各种重要化学和生物转化的关键步骤.在这项工作中,我们通过氢化硅烷化途径完成了羧酸的多电子还原,其中 Co(Ply-O,O) 2 (Thf) 2中的氧化还原活性苯酚基主链存储电子并在整个反应中发挥着主导作用.过程.这种还原通过单还原配体主链的单电子转移 (Set) 进行,导致 Si-H 键断裂.催化还原反应中的几个重要中间体已被分离并得到充分表征,以证明氧化还原当量通过配体脱芳构化过程以 C-H 键的形式存储在 Ply 主链中.通过氘标记实验已经最终阐明了配体广泛参与存储氢化物当量.这是一个罕见的例子,其中配体协调多电子还原过程,仅留下金属来维持构象要求并微调催化剂的电子学.
Doi:10.1039/c9Sc02057H

专利信息

专利号:US-10040752-B2
优先权日:2015-08-24
标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
发明人：MKRTCHYAN GNEL; YAO QINGWEI
权利人:CODY LABORATORIES INC
摘要:Highly efficient methods for synthesis of levomethadone hydrochloride or dextromethadone hydrochloride are provided starting from D-alanine, or L-alanine, respectively, with retention of configuration. Methods for treating a subject are provided comprising administering a composition comprising an effective amount of levomethadone hydrochloride having not more than 10 ppm dextromethadone.

专利号:US-7968752-B2
优先权日:2003-06-16
标 题:Hydrolytically-resistant boron-containing therapeutics and methods of use
发明人：LEE VING; PLATTNER JACOB J; BENKOVIC STEPHEN J; BAKER STEPHEN J; MAPLES KIRK R; BELLINGER-KAWAHARA CAROLYN; AKAMA TSUTOMU; ZHANG YONG-KANG; SINGH RAJESHWAR; SAURO VITTORIO A
权利人:ANACOR PHARMACEUTICALS INC
摘要:Compositions and methods of use of borole derivatives, including benzoxaboroles, benzazaboroles and benzthiaboroles, as therapeutic agents for treatment of diseases caused by bacteria or viruses are disclosed, as well as methods for synthesis of said agents and compositions thereof.

专利号:US-6147159-A
优先权日:1998-09-30
标 题 :Compositions for organic synthesis on solid phase and methods of using the same
发明人：HU YONGHAN; LABADIE JEFFREY W; PORCO JR JOHN ANTHONY; TROST BARRY MARTIN
权利人:ARGONAUT TECHNOLOGIES
摘要:A modified solid support for use in solid phase synthesis which comprises: a solid support having a linker group extending therefrom having the general formula: wherein R1 and R2 are each independently selected from the group consisting of alkyl, cycloalkyl, aryl, alkoxy, aryloxy, fluorine, chlorine, iodine and bromine.

专利号:US-8513465-B2
优先权日:2008-02-04
标题:Potassium organotrifluoroborate derivative and a production method therefor
发明人：KANG HEONJOONG; HAM JUNGYEOB; AHN HONG RYUL; PARK YOUNG HEE
权利人:KANG HEONJOONG; HAM JUNGYEOB; AHN HONG RYUL; PARK YOUNG HEE; SNU R&DB FOUNDATION
摘要:Provided are a production method for a potassium organotrifluoroborate compound having a hydroxyl group, and a novel potassium organotrifluoroborate compound having a hydroxyl group. The production method is advantageous in that a potassium organotrifluoroborate compound can be produced in a single reaction without recourse to a process of isolating and purifying an intermediate. The novel potassium organotrifluoroborate compound having a hydroxyl group is useful as a reactant which is widely used in the total synthesis of physiologically active natural products and diverse organic synthesis reactions including halogen substitution reactions, 1,2- and 1,4-addition reactions using a rhodium (Rh) catalyst, and Suzuki coupling reactions using a palladium (Pd) catalyst.

专利号:US-2019002394-A1
优先权日:2015-08-24
标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof

专利号:EP-1836163-B1
优先权日:2004-12-23
标题 :Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
发明人：BREITENSTEIN WERNER; COTTENS SYLVAIN; EHRHARDT CLAUS; JACOBY EDGAR; LORTHIOIS EDWIGE LILIANE JEANNE; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; SELLNER HOLGER; SIMIC OLIVER
权利人:NOVARTIS AG
摘要:Novel 3-mono-, 3,4-di- and 3,4,4,-tri-substituted pyrrolidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on inappropriate activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on inappropriate activity of renin; the use of a compound of that class in the treatment of a disease that depends on inappropriate activity of renin; pharmaceutical formulations comprising a said substituted pyrrolidine compound, and/or a method of treatment comprising administering a said substituted pyrrolidine compound, a method for the manufacture of said substituted pyrrolidine compounds, and novel intermediates and partial steps for their synthesis are described. The substituted pyrrolidine compounds are especially of the formula I wherein the substituents are as described in the specification.